5-Bromo-1,3-benzothiazol-2(3H)-one(CAS: 199475-45-1)

5-Bromo-1,3-benzothiazol-2(3H)-one (CAS: 199475-45-1) is regulated under the Globally Harmonized System of Classification and Labelling of Chemicals (GHS), REACH regulations in the European Union, and the Occupational Safety and Health Administration (OSHA) under the United States. Specific handling and storage guidelines, including personal protective equipment (PPE) and emergency procedures, are outlined in these regulatory frameworks.

Yes, there are alternatives to 5-Bromo-1,3-benzothiazol-2(3H)-one (CAS: 199475-45-1) in synthesis, such as 5-Chloro-1,3-benzothiazol-2(3H)-one and 5-Iodo-1,3-benzothiazol-2(3H)-one. These bromo analogs can be substituted based on the desired reactivity and functional group requirements of the reaction.

The market for 5-Bromo-1,3-benzothiazol-2(3H)-one (CAS: 199475-45-1) is growing with increasing research interest in its use as a medicinal intermediate, particularly in the development of anti-inflammatory and antiviral drugs. Emerging research focuses on its application in drug discovery and synthesis optimization.

Waste containing 5-Bromo-1,3-benzothiazol-2(3H)-one (CAS: 199475-45-1) should be collected in sealed containers and stored in a well-ventilated area. It should be disposed of through a licensed hazardous waste disposal service to ensure compliance with environmental regulations. Proper incineration or neutralization followed by safe disposal is recommended to minimize environmental impact.